
Kronos Bio, Inc. (NASDAQ:KRON) shares are trading higher on Wednesday in the premarket session.
The firm announced significant leadership and operational changes. Deborah Knobelman has been appointed as the company's new President and Interim Chief Executive Officer, effective December 3, 2024.